Clinical trials have demonstrated that GLP-1 agonists can reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death [5, 7]
They both slow digestion, affect appetite centers in the brain, and improve glucose metabolism
This gives your digestive system practice operating in smaller-portion mode before the medication makes it necessary
Cutting Through the Marketing Spin B12 and MIC B12 injections aren't miracle workers
By balancing protein, carbs, and fat, it not only curbs hunger like GLP-1 drugs but also enhances AMPK activation, leading to a greater reduction in inflammation
Furthermore, some experiments demonstrated that LG could serve as an important intervention in NASH, which increased adipose insulin sensitivity (49)